Aprogen Medicines Inc.

A007460

KR7007460009

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
1,354 ^KRW	-7.89%		-10.45%	+41.04%

Mar. 19	Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	CI

Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.

January 20, 2021

On January 21, 2021, Aprogen KIC Inc. (KOSE:A007460) closed the transaction.

Latest news about Aprogen Medicines Inc.

Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	Dec. 10	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding	23-10-22	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding	23-10-12	CI
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding	23-09-13	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding	23-09-07	CI
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.	23-04-11	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.	22-10-03	CI
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.	22-07-17	CI
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.	21-11-17	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	21-09-15	CI
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	21-01-20	CI
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	21-01-13	CI
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	21-01-06	CI
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	20-10-12	CI
Aprogen KIC Inc. announced that it expects to receive KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	20-10-11	CI
Aprogen KIC Inc. cancelled the acquisition of remaining stake minority in Aprogen, Inc.	20-09-07	CI
Aprogen KIC Inc. cancelled the acquisition of Aprogen Healthcare & Games Inc..	20-09-07	CI
Aprogen KIC Inc. agreed to acquire Aprogen Healthcare & Games Inc. for approximately KRW 140 billion.	20-04-23	CI
Aprogen KIC Inc. signed a merger agreement to acquire remaining stake minority in Aprogen, Inc.	20-04-23	CI
Aprogen KIC Inc. announced that it has received KRW 70 billion in funding from Korea Fixed-Income Investment Advisory and other investors	20-03-17	CI

Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Welding & Soldering Equipment

	1st Jan change	Capi.
APROGEN MEDICINES INC.	+41.04%	266M
LINCOLN ELECTRIC HOLDINGS, INC.	+4.37%	12.99B
ESAB CORPORATION	+24.72%	6.57B
HAN'S LASER TECHNOLOGY INDUSTRY GROUP CO., LTD.	+1.83%	3B
WUXI AUTOWELL TECHNOLOGY CO.,LTD.	-8.09%	2.6B
WUHAN RAYCUS FIBER LASER TECHNOLOGIES CO.,LTD.	-12.83%	1.57B
ESAB INDIA LIMITED	+0.55%	1.1B
SBT ULTRASONIC TECHNOLOGY CO.,LTD.	-35.82%	772M
SHANGHAI HUGONG ELECTRIC GROUP CO.,LTD.	+1.56%	644M
SHENZHEN UNITED WINNERS LASER CO., LTD.	-32.86%	627M

Welding & Soldering Equipment

Aprogen Medicines Inc.

Equities

A007460

KR7007460009

Industrial Machinery & Equipment

Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.

Latest news about Aprogen Medicines Inc.

Chart Aprogen Medicines Inc.

Company Profile

Income Statement Evolution

Sector Welding & Soldering Equipment